Related Experiment Video
Updated: Feb 17, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Pharmacologic Complement Inhibition in Clinical Transplantation
Vasishta S Tatapudi1, Robert A Montgomery2
1Division of Nephrology, Department of Internal Medicine, NYU Langone Medical Center, New York, NY 10016 USA.
Pharmacologic complement inhibition shows promise for preventing antibody-mediated rejection (AMR) in kidney transplant recipients. Complement blockade therapies are emerging as valuable tools for improving transplant outcomes, especially in highly sensitized patients.
Area of Science:
- Transplantation immunology
- Pharmacology
Background:
- The complement system plays a critical role in antibody-mediated rejection (AMR).
- Advances in understanding complement's role have spurred the development of targeted therapies.
Purpose of the Study:
- To review recent progress in pharmacologic complement inhibition for clinical transplantation.
- To assess the impact of complement inhibition on transplant recipient outcomes.
Main Methods:
- Review of recent clinical studies and prospective trials.
- Analysis of data on complement inhibitors in various transplant settings.
Main Results:
- Terminal complement inhibition with eculizumab prevented acute AMR in HLA-incompatible renal transplants.
- C1 esterase inhibitor (C1-INH) improved renal allograft function in AMR treatment.
- Complement inhibitors are being tested for AMR, post-transplant aHUS, C3 glomerulopathies, and APS.
Conclusions:
- Pharmacologic complement inhibition is a valuable therapeutic strategy, particularly for highly sensitized renal transplant recipients.
- Novel complement-targeting agents are under development for transplantation.
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...